Continuous Positive Airway Pressure

In patients with obstructive sleep apnea and poor CPAP adherence, domiciliary transcutaneous electrical stimulation for 3 months improved disease severity compared with CPAP, according to results published in eClinicalMedicine.

The risk for death and hospitalizations due to cardiovascular disease in patients with obstructive sleep apnea decreased with use of CPAP, according to a presentation at the European Respiratory Society International Congress.

The likelihood for nocturnal gastroesophageal reflux, wheeze and cough declined with use of positive airway pressure for 2 years in patients with obstructive sleep apnea, according to results published in ERJ Open Research.

WASHINGTON — Positive airway pressure device compliance went down 90 days after a clinic visit among patients with Down syndrome, according to an abstract presented at the American Thoracic Society International Conference.

The FDA has designated Draeger Medical’s recall of the Seattle-Positive Airway Pressure Plus system as a class I recall, the most serious kind.

WASHINGTON — Among patients with Parkinson’s disease, obstructive sleep apnea and decreased cognition, CPAP therapy improved cognitive function, according to an abstract presented at the American Thoracic Society International Conference.

Fewer patients with respiratory failure related to COVID-19 using helmet CPAP experienced intubation compared with facemask CPAP, according to study results published in CHEST.

Healio has compiled the most-read news in pulmonology posted in April.

The FDA has designated Philips Respironics’ recall of DreamStation devices as a class I recall, the most serious kind.

More patients without continuous airway positive pressure coverage in their region said that cost affected their choice of treatment than patients with CPAP coverage, according to results published in Annals of the American Thoracic Society.